FR21C1059I2
(en)
|
|
PHARMACEUTICAL COMPOSITIONS
|
BR112015002738A2
(en)
|
|
compound and pharmaceutical composition
|
DK3030262T3
(en)
|
|
COMBINED PHARMACEUTICAL COMPOSITION
|
DK3181128T3
(en)
|
|
NILOTINIB PHARMACEUTICAL COMPOSITION
|
DK2694038T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
BR112014003052A2
(en)
|
|
pharmaceutical compositions
|
BR112015003259A2
(en)
|
|
compound, pharmaceutical composition, and vaccine composition.
|
DK3246018T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
DK3043778T3
(en)
|
|
PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
|
DK2900645T3
(en)
|
|
HERBICID ACTIVE 3-PHENYLISOXAZOLINE DERIVATIVES
|
BR112014032798A2
(en)
|
|
composition
|
CO6930367A2
(en)
|
|
Pharmaceutical compositions
|
EE201300005A
(en)
|
|
Pharmaceutical composition
|
CO7020919A2
(en)
|
|
Tetrahydroquinazolinone derivatives
|
DK2897594T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
CO6940426A2
(en)
|
|
Pharmaceutical formulations
|
DK2815752T3
(en)
|
|
ORAL PHARMACEUTICAL COMPOSITION
|
CL2014003283A1
(en)
|
|
Pharmaceutical formulation
|
BR112015010797A2
(en)
|
|
substituted anionic compounds and pharmaceutical composition
|
DK2854765T3
(en)
|
|
PHARMACEUTICAL PEMETREXED SOLUTION
|
FR2986872B1
(en)
|
|
.
|
BR112014032712A2
(en)
|
|
composition
|
CO7091176A2
(en)
|
|
Pharmaceutical diagnosis
|
BR112015002646A2
(en)
|
|
compound and pharmaceutical composition
|
BR112015002979A2
(en)
|
|
crystalline form and pharmaceutical composition
|